Translation of mRNA is a highly regulated process that is tightly coordinated with cotranslational protein maturation. Recently, mRNA modifications and tRNA modificationsthe so called epitranscriptomehave added a new layer of regulation that is still poorly understood. Both types of modifications can affect codon-anticodon interactions, thereby affecting mRNA translation and protein synthesis in similar ways. Here, we describe an updated view on how the different types of modifications can be mapped, how they affect translation, how they trigger phenotypes and discuss how the combined action of mRNA and tRNA modifications coordinate translation in health and disease.
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Keywords: disease; epitranscriptome; post-transcriptional modifications; ribosome; RNA modification; RNA sequencing; translation Protein synthesis is essential to life. Thus, it is regulated by a variety of sophisticated mechanisms and comprises four phases: (a) initiation; (b) elongation; (c) termination; and (d) ribosome recycling. Initiation is the key regulatory step of translation, and different mechanisms have been discovered that lead either to a global or transcript-specific control of translation initiation [1] . However, translation initiation is not the only option for the cell to regulate protein synthesis. Translation elongation comprises mRNA decoding, peptide-bond formation and tRNA-mRNA translocation, resulting in nascent-peptide elongation, and each of these steps bears regulatory potential for translation. Furthermore, mRNA translation occurs in concert with protein maturation. As soon as the nascent-peptide chain emerges from the ribosome during protein synthesis, proteins begin to fold into their final three-dimensional structure and acquire protein modifications [2] .
Some of the key players in translation like mRNA, tRNA or ribosomes are RNA molecules or contain RNA molecules, essential to their function. These can be post-transcriptionally modified by a plethora of chemical modifications, which currently amount to more than a hundred seventy [3] [4] [5] . Some of these RNA modifications are evolutionary conserved and were linked to a human disease [6] [7] [8] . Since RNA modifications change the structural and chemical properties of RNA molecules, some modifications of either mRNA, tRNA or rRNA are thought to optimize translation dynamics in the cell, whereas others may be neutral to translation [5] . In particular internal Abbreviations ac 4 C, N 4 -acetylcytidine; eIF, eukaryotic initiation factor; hm 5 C, 5-hydroxymethylcytosine; IP, immunoprecipitation; m 5 C, 5-methylcytosine; m 6 A, N 6 -methyladenosine; m 6 Am, N 6 ,2 0 -O-dimethyladenosine; RT, reverse transcription; SAM, S-adenosyl-L-methionine; sm 5 U, 5-taurinomethyluridine; U34, wobble uridine. mRNA modifications and tRNA anticodon modifications likely lead to very similar effects, since the codon and the anticodon interact directly during decoding. Importantly, the reversibility of both types of modifications suggests a new, essentially unexplored layer of the control of gene expression that has been termed the epitranscriptome [9, 10] . However, how particular mRNA or tRNA modifications affect translation is largely unknown because the analysis of eukaryotic translation in vitro or in vivo and the identification of internal mRNA modifications is very challenging.
Here, we discuss our emerging understanding of the role of mRNA modifications [N 6 -methyladenosine (m 6 A), 5-methylcytosine (m 5 C), N 4 -acetylcytidine (ac 4 C), 2 0 -O-methylation] and tRNA wobble uridine (U34) modifications in translation and how our understanding of the roles of mRNA modifications is influenced by current mapping approaches. Finally, we comment on general implications for disease. This article aims to convey a broad picture of how mRNA and tRNA modifications act in concert to control translation. For a more focused discussion of mRNA and tRNA modifications we refer the readers to several recent reviews [9, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Internal mRNA modifications and their mapping
Internal modifications of mRNA and long noncoding RNA have already been discovered in the 1970s [21] [22] [23] . However, due to their low abundance they generally evaded biochemical analyses and we lacked the ability to map their positions in a transcriptome-wide manner. mRNA modification mapping has become possible only recently, with the advent of deep sequencing and the implementation of specialized sequencing-based protocols. In general, successful mapping approaches are based on three strategies: (a) the induction or detection of specific mutations in RNAseq experiments; (b) termination of reverse-transcription (RT) reactions and (c) antibody-based enrichment of modification sites (extensively reviewed in [18] ). Direct RNA sequencing appears as a promising future alternative and has been shown to detect modified bases in synthetic RNA strands or abundant cellular targets [24] . However, these protocols have not been shown to work reliably on a transcriptome-wide level, yet. It is important to realize that the low abundance of mRNA modifications in combination with false-positive rates in their detection has remained a challenge. Due to the lack of quantitative high-quality mRNA modification maps for most organisms we cannot easily correlate translational phenotypes to the occurrence of mRNA modifications. This has prevented us from understanding the in vivo roles of mRNA modifications and in particular from understanding their effects during translation.
The most abundant internal mRNA modification is m 6 A, which is present on average at 3 positions per mRNA molecule (Box 1). In addition to m 6 A, pseudouridine (Ψ), N 1 -methyladenosine (m 1 A), N 6 ,2 0 -Odimethyladenosine (m 6 Am), as well as m 5 C (Box 2) and its oxidation product 5-hydroxymethylcytosine (hm 5 C), ac 4 C and 2 0 -O-methylated nucleotides were mapped to the transcriptome. Additional modifications were reported based on measurements by RNA mass spectrometry but their position has not been determined throughout the transcriptome [9, 25] . The complex modification pattern of the transcriptome likely differs between species and even between different tissues in one organism [26] . However, a complete map of all modifications in all cell types, still needs to be achieved and will require concerted efforts from many labs comparable to consortia like the ENCODE project [27] .
Internal mRNA modifications in translational regulation
The recent identification of proteins that install (writers), recognize (readers) and remove (erasers) m 6 A and other modifications has revealed mechanisms how mRNA modifications can affect nearly every aspect of the mRNA life cycle, as well as various cellular, developmental and disease processes. However, for understanding their effects in translation, we currently have to mostly rely on biochemical and biophysical analyses. Using an in vitro protein synthesis kit containing the components for in vitro transcription and translation, named 'PUR-Express translation system' with m 5 C, m 6 A, Ψ or 2 0 -O-methylated nucleotides at each position within a codon revealed that protein synthesis is strongly affected by nucleotide modifications in a position-specific manner [28]. 2 0 -O-methylated nucleotides at the 1st codon position affect translation only marginally; however, when placed at the 2nd position the same modification causes an almost complete stop of protein synthesis. Introduction of multiple modified nucleotides within one codon increased the translation inhibition [28] . More specifically, the presence of 2 0 -Omethylation at the 2nd codon position of mRNA strongly delays tRNA accommodation to the modified codon [29] . Furthermore, 2 0 -O-methylation impairs the initial and proofreading selection of aminoacyl-tRNA and the interaction between the codon-anticodon helix and ribosomal-monitoring bases [29] . Such alterations of codon-anticodon interaction can even change the identity of the incorporated amino acid as the presence of m 5 C at the 2nd codon position of CCCa proline codonleads to an amino acid-substitution by either isoleucine or leucine [28] .
A FRET-based assay using a bacterial translation system revealed that m 6 A at the 1st codon position strongly inhibits translation elongation dynamics [30] . m 6 A acts as a barrier to tRNA accommodation when present at the 2nd codon position. However, when present at the 3rd codon position of the near-cognate codon m 6 A essentially does not affect tRNA selection rate during translation elongation [30] . In addition, to the position of the modification, the sequence context also has a significant modulatory effect [28, 30] . For instance m 6 A in the glutamine (CAG) or proline (CCA) slowed translation elongation and Ψ at the 1st position of the UAA stop codon increases translational read-through [30, 31] . However, translation elongation is not the only step that can be affected by nucleotide modifications. m 6 A like the cap, when present in the 5 0 UTR of mRNAs can modulate translation initiation. Even a single m 6 A nucleotide in the 5 0 UTR induces direct binding of mRNA to eukaryotic initiation factor 3 (eIF3), and is sufficient to recruit the 43S complex to initiate translation in the absence of the cap-binding initiation factor, eIF4E [32] . Following heat shock, m 6 A was found more frequently in Hsp70 mRNA regulating its cap-independent translation [32] , an effect that appears to be mediated by ABCF1, a key factor in m 6 A-promoted translation under both physiological and stress conditions [33] .
Transcriptome-wide mapping of the ac 4 C, catalysed by acetyltransferase NAT 10, revealed ac 4 C enrichment within coding regions of mRNA [34] . Furthermore, mRNA stability was decreased in NAT10-
Box 1: Mapping of m 6 A sites
The mapping of m 6 A sites is the classical example for detection based on modification-specific antibodies [80, 81] . Early protocols randomly fragment the mRNA and enrich m 6 A-containing mRNA fragments by immunoprecipitation (IP) using m 6 A-specific antibodies. The purified mRNA pool and a negative control are subsequently converted to cDNA and sequenced. Putative m 6 A sites are identified as m 6 A peaks that are absent in the control. While this strategy is sufficient to identify the position of m 6 A sites at a global level, it does not reach nucleotide resolution. Nucleotide resolution was later achieved by UV cross-linking the antibodies to mRNA prior to the IP called individual-nucleotideresolution cross-linking and IP (miCLIP) [19, 82, 83] . The cross-link between RNA and the antibody leads to characteristic nucleotide substitutions that can be detected in the sequencing reaction. Antibody-based purification strategies have also been used for m 1 A, m 6 Am, hm 5 C and ac 4 C [18, 19] . While m 1 A interferes with Watson-Crick basepairing, m 6 A is not distinguished from adenosine by standard RT enzymes. However, different strategies can be used to increase the mutation rates in such experiments like varying the concentration of dNTPs, using modified polymerases that are sensitive towards specific modifications or using selenium-modified deoxythymidine triphosphate analogues [84] [85] [86] . An orthogonal strategy is to use analogues of S-adenosyl-L-methionine (SAM) [87] . Since SAM analogues are unstable under physiological conditions, cells are fed with propargyl-L-selenohomocysteine, which is converted to the respective SAM analogue by the cellular methionine adenosyltransferase [87] . Subsequently, cellular methyltransferases, which are often promiscuous towards their substrate use the SAM analogue and incorporate the methyl derivate into mRNA. The artificial label can then be used to enrich the labelled mRNA by chemical click reactions and to induce mutations and/or strand termination in the RT reaction [87] .
Box 2: Mapping of m 5 C sites m 5 C was the first modified nucleotide, which was mapped to the entire transcriptome after adapting bisulfiteconversion sequencing to RNA [17] . The method takes advantage of the fact that methylation changes the chemical reactivity of cytidine. While acidic bisulfite deamination converts cytidine to uridine, m 5 C is resistant to this conversion reaction. Therefore, the detection of m 5 C relies on the identification of cytidines that do not convert in response to bisulfite treatment. In identifying thousands of m 5 C sites throughout the transcriptome RNA-bisulphite sequencing has become the first example for identifying internal mRNA modifications in high throughput. However, the high number of m 5 C sites has been questioned, showing how much care needs to be taken not to misinterpret modification marks that may be the result of single-nucleotide polymorphisms, inefficient chemical reactions or sequencing errors [20, 88] .
deleted HeLa cells indicating that ac 4 C actively promotes mRNA stability and enhances translation. ac 4 C is strongly enriched in the 5 0 end of mRNA, however, no effect of ac 4 C on the formation of 48S preinitiation complex was observed by in vitro analysis, demonstrating that ac 4 C does not affect translation initiation [34] . Finally, ribosome-profiling data show increased ribosome occupancy for acetylated mRNA mediated by NAT10, suggesting that ac 4 C intrinsically promotes translation, a finding further supported in vivo by the quantification of translation products from parental and NAT10-depleted cells [34] .
Taken together, the emerging data suggest a direct impact of internal mRNA modifications on gene expression, primarily through translation.
tRNA modifications and their mapping tRNAs contain the largest diversity of modified nucleotides [12, 35] . Eukaryotic tRNAs contain on average 13 modifications, including various methylations, pseudouridine, dihydrouridine, thiolation and others. Modifications are found throughout the tRNA molecule, with a hotspot in the anticodon loop. The modifications in the anticodon loop fine-tune decoding, translational fidelity and translational efficiency, whereas tRNA modifications outside the anticodon loop mainly affect tRNA stability and modulate tRNA folding [12] . Furthermore, both classes of modifications act as determinants for aminoacyl-tRNA synthetase binding to tRNA. In recent years, numerous independent studies established an unexpected role of tRNA modifications and the enzymes catalysing such modifications for the aetiology of complex human pathologies including cancer, neurological and respiratory disorders and mitochondrial diseases [6] [7] [8] 36 ]. Compared to mRNA, tRNA are very abundant. Hence, their modifications have been characterized using RNA mass spectrometry and biochemical methods, whereas similar methods were challenging for mRNA [37] . Nevertheless, the simultaneous quantification of tRNA and their modifications in high throughput remains challenging, since sequence-specific RNA mass spectrometry is not commonly used and some RNA modifications perturb sequencing-based detection. However, recent tRNA-sequencing protocols like ARM-Seq have improved the situation [38, 39] .
Wobble uridine in translational processivity
The ability of cells to respond and to adapt to dynamically changing external conditions and stimuli are ensured by the coordinated processes of transcription, translation and maintenance of protein homeostasis. During this process, tRNA modifications appear critical for maintaining this coordination [40] [41] [42] . In all known organisms wobble U34 carries a complex modification at its 5 0 position and a 2-thio-group (s 2 U) in tRNA Lys(UUU) , tRNA Gln(UUG) and tRNA Glu(UUC) . These tRNA decode A-ending codons of split codon boxes where U-and C-ending codons code for a different amino acid. Furthermore, U34 modifications were shown to be a determinant of efficient aminoacylation of tRNA Glu and tRNA Gln by increasing the binding affinity of the synthetase in Escherichia coli but not in yeast [43] [44] [45] . On the ribosome, tRNA wobble modifications are implicated in maintaining accurate decoding and translational processivity. In bacteria, cmo 5 U34 in tRNA Ala(UGC) facilitates the decoding of codons ending with A, G and U, according to the wobble rules, but also the C-ending codon with reduced efficiency [46] . In tRNA Gln(UUG) s 2 U34 affects the hydrolysis of GTP by EF-Tu and subsequently dipeptide formation [47] . Since the ratio between the rates of GTP hydrolysis and peptide bond formation is similar for s 2 U modified and unmodified tRNA Gln(UUG) , it is likely that the modification preferentially affects GTP hydrolysis and inorganic phosphate (Pi) release with little effect on later steps in decoding [47] . In eukaryotes, tRNA Lys(UUU) , tRNA Gln(UUG) and tRNA Glu(UUC) are decorated by 5-methoxycarbonylmethyl-2-thiouridine (mcm 5 s 2 U34). The absence of either of the two modifications leads to a codon-specific slowdown of translation of the AAA and CAA codons, which are decoded by tRNA Lys(UUU) , tRNA Gln(UUG) [40, 48] . GAA is not decoded more slowly in the yeast mutant, consistent with the observation that readingframe maintenance of these codons depends on the mcm 5 s 2 U modifications only for tRNA Lys(UUU) and tRNA Gln(UUG) [49] and that the overexpression of tRNA Glu(UUC) is not able to rescue growth phenotypes [50, 51] . Hence, the absence of the modifications affects the global translation of a subset of mRNAs enriched for codons that are read by these tRNAs [52] . A comparison of the decoding properties of native modified and unmodified tRNAs in an in vitro translation system showed that U34 modifications increase the affinity of the tRNA to its cognate codon in the A site of the ribosome [46, 52] . Also the rate of peptide-bond formation at saturating concentrations of the ternary complex is slower in the absence of s 2 U34 or mcm 5 U34 [52] . A real-time kinetic analysis shows that hypomodified tRNA Lys(UUU) that only carries mcm 5 U34 but lacks s 2 U34 binds to its cognate codon with a lower affinity and is more frequently rejected than the fully modified tRNA Lys(UUU) . Nevertheless, the rate of peptide-bond formation remains unaffected [53] . Altogether, these data demonstrate a role of tRNA wobble uridine modifications at the initial steps of decoding and also during the proofreading step [53] .
But how are the observed translational defects linked to phenotypes and to the regulation of gene expression? Several studies have shown that 2-thiolation of tRNA Lys(UUU) , tRNA Gln(UUG) and tRNA Glu(UUC) is decreased at elevated temperature in yeast [54] [55] [56] [57] and that this effect is reversible when normal growth conditions are restored [56, 57] . A study utilizing quantitative mass spectrometry and northern-blot analyses showed a decrease in s 2 U34 under permissive growth conditions upon nutrient starvation. However, thiolation pattern remained unaffected when sufficient nutrients were supplied at elevated growth temperature, thereby establishing that the reduction in 2-thiolation under heat stress is independent of nutrient availability [54] . Under most circumstances, the lack of tRNA modifications induces cellular stress and negatively affects cell growth and survival [58] . Nevertheless, the absence of tRNA modifications can also be beneficial in specific cases, for example by conferring resistance to endoplasmic reticulum stress [55] or resistance to long-term nutrient starvation [59] . This indicates that the link between wobble uridine modifications and stress is more complex than it seems.
Hypomodification and protein homeostasis
Modifications of tRNA optimize translation dynamics, which is crucial to maintain cellular homeostasis [40, 60] . Several studies have characterized mutants that are deficient in wobble uridine modification using RNAseq, ribosome profiling and quantitative proteomics [40, 48, 52, 54] . While no major translation defect was apparent based on S 35 incorporation and polysome profiling [40, 52] , gene ontology analysis of downregulated genes and proteins linked the loss of U34 modifications to processes like rRNA synthesis and processing, ribosome biogenesis, tRNA synthesis and modification, electron transport chain and oxidative phosphorylation, and translation regulation, which are typically downregulated during the response to numerous stresses [40, 52, 54, 61, 62] . Analyses of codon translation by ribosome profiling in yeast cells lacking wobble uridine modifications revealed a seemingly mild enrichment of 20% of AAA and CAA codons in the A site of mutant ribosomes relative to wild-type [40, 48, 63] . This is in agreement with a slight enrichment of AAA, CAA and GAA codons in mRNAs that appear reduced at the proteomic level [52] and an in vitro study that showed that the absence of s 2 U34 affects the stability of tRNA Lys(UUU) binding to the ribosome during decoding and impedes rotation of ribosomal subunits upon tRNA-mRNA translocation [53] . The lack of s 2 U34 modification increases the length of the decoding steps and slows down translocation such that the residence time of the ribosomes on Lys-codon AAA increased by 20-40%, clearly accounting for the modest increase in the ribosome occupancy revealed by ribosome profiling [40, 48, 53] . Strikingly, however, the subtle translation defects are accompanied by a perturbation of in cellular protein homeostasis leading to the upregulation of cytoplasmic chaperones and the proteasome and lead to the formation of protein aggregates in the mutants [40] (Fig. 1) . Similar phenotypes were observed in different modification mutants and may point to a common mechanism how defects in tRNA modifications induce phenotypes [41, 64] . Interestingly, protein aggregates isolated from such cells are similar to those induced by the loss of ribosome-associated chaperones, responsible for cotranslational folding of nascent polypeptides and preventing them from incorrect folding [40, 65] . Finally, the protein aggregates in wobble uridine modification mutants are not enriched for AAA, CAA and GAA codons, but contain mainly proteins that are known to be metastable [40, 65] . Taken together, the absence of tRNA modifications induces seemingly mild effects on translation dynamics. However, those perturbations can significantly impact on cellular viability through its profound negative effect on protein homeostasis.
The epitranscriptome: implication in disease
Mutations in nearly half of the RNA modification enzymes have been linked to human diseases, including cancer, neurological disorders, genetic birth defects, cardiovascular diseases, mitochondrial-linked defects and metabolic disorders [8] (Fig. 2) . Interestingly, amongst the diseases that have been associated with mutations in RNA modifying enzymes, neurological disorders are the most prevalent. This is in agreement with the observed enrichment of various RNA modifications in neuronal tissues [66, 67] . The m 5 C methyltransferase NSUN2 has been associated with defects in memory and learning in Drosophila [68] . Furthermore, tRNA fragments were shown in NSUN2-deficient mice, which may activate apoptosis in the brain [69] . RNA demethylation has also been linked to neurological defects. The deletion of the RNA demethylase FTO in mice results in an impairment of dopamine receptor control of neuronal activity and behaviorial responses [70] . ALKBH5, a second m 6 A demethylase has been associated to major depressive disorders [71] . In addition, mutations that affect 5-taurinomethyluridine (sm 5 U) biosynthesis in mitochondrial tRNAs are associated with mitochondrial diseases and affect the translation of lysine and leucine codons. MTO1 and GTPBP3 catalyse the formation sm 5 U and GTPBP3-knockout exhibit respiratory defects and reduced mitochondrial translation, however, little is known about the mechanism [72] [73] [74] .
Defects in tRNA modifications and mRNA modifications have also been directly tied to cell proliferation and malignancy in a number of lymphomas, leukaemias and carcinomas, including breast, bladder and colorectal cancers [6, [75] [76] [77] . Elp3 and Ctu1/2, enzymes responsible for mcm 5 s 2 modification are upregulated in breast cancer and were shown to be required to sustain metastasis [78] . NSUN2 is a direct target gene of c-Myc, a well-known proto-oncogene and has been found to be upregulated in primary tumours and metastases of breast carcinomas [79] . The reduction in m 6 A levels through knockdown of Mettl3 results in tumour progression [77] . Taken together, these point to a crucial role of RNA modifications in human diseases.
Concluding remarks
This review aims to summarize the emerging view of internal mRNA and tRNA modificationsthe so called epitranscriptomeas regulators of translation and protein homeostasis. In the last decade we have learned how RNA modificationsin particular in the tRNA anticodon and the newly discovered internal mRNA modificationsaffect RNA metabolism in unexpected ways, thus adding an unchartered layer to translation regulation. It will be exciting to follow how new modifications will be mapped to the transcriptome under different conditions. However, most importantly we will discover how those marks in trigger phenotypes and facilitate physiological effects in different species. An important step will be the further improvement of modification mapping. Deep-sequencing-based methods have already made invaluable contributions to our understanding of modified nucleosides and the integration of additional enzymes and further improvements of antibody-based strategies, will provide us with novel insights.
One of the major recent advances was the discovery how internal mRNA modifications affect gene expression and translation. While most of the studies were performed using single mRNA modifications, it will be very interesting to study the cross-talk between various of this modification marks. Furthermore, it will be important to understand whether tRNA modifications play a role in decoding modified mRNA nucleotides and in particular how modified mRNA nucleotides interact with tRNA anticodon modifications during translation. In the light of data highlighting the impact of tRNA wobble modifications for translation quality through optimizing decoding, translocation and ribosome density, it appears worthwhile to explore the roles of other tRNA modifications. It is now well established that gene expression regulation and human diseases are affected by tRNA modifications. It will be similarly important to understand which human pathologies are linked to mRNA modifications. The importance of RNA modifications for translation dynamics as well as their potential to perturb translation elongation will eventually tell us whether the two types of modifications are indeed equal sides of the coin or whether translation is a coin with a flipside.
